Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia
· Delayed Price · Currency is AUD 3.040
0.00 (0.00%)
At close: Dec 5, 2025
Clarity Pharmaceuticals Employees
Clarity Pharmaceuticals had 69 employees as of June 30, 2025. The number of employees increased by 19 or 38.00% compared to the previous year.
Employees
69
Change (1Y)
19
Growth (1Y)
38.00%
Revenue / Employee
137.14K AUD
Profits / Employee
-931.82K AUD
Market Cap
1.13B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 69 | 19 | 38.00% |
| Jun 30, 2024 | 50 | 9 | 21.95% |
| Jun 30, 2023 | 41 | 11 | 36.67% |
| Jun 30, 2022 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 29,904 |
| Pro Medicus | 132 |
| Cochlear | 5,500 |
| Sonic Healthcare | 45,000 |
| Ramsay Health Care | 90,000 |
| Ansell | 15,000 |
| Telix Pharmaceuticals | 234 |
| Mesoblast | 81 |
Clarity Pharmaceuticals News
- 7 weeks ago - Clarity Pharma Co-PSMA Trial Meets Main Goal, Detects More Prostate Cancer Lesions Than Standard One - Nasdaq
- 4 months ago - Greatland Resources, Clarity Pharma headline huge ASX 200 rebalance - The Australian Financial Review
- 4 months ago - Clarity Pharmaceuticals readies mega capital raising - The Australian Financial Review
- 1 year ago - Indoco Remedies stock surges 8% on partnership with Clarity Pharma in the UK - Business Upturn
- 1 year ago - Indoco Remedies partners with Clarity Pharma to strengthen UK presence - Business Upturn
- 1 year ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
- 1 year ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review